Just a moment...
Press 'Enter' to add multiple search terms. Rules for Better Search
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
No Folders have been created
Are you sure you want to delete "My most important" ?
NOTE:
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
Don't have an account? Register Here
Hyderabad, Apr 4 (PTI) Indian pharmaceutical exports stood at over USD 28 billion up to February this financial year registering a growth of five per cent compared to the same period last ear, a top official said on Saturday.
K Raja Bhanu, Director General, Pharmaceuticals Export Promotion Council of India (PHARMEXCIL) said the sector, currently valued at approximately USD 60 billion, is projected to grow to USD 130 billion by 2030.
"Inspite of global challenges, pharmaceuticals exports have been one of the few sectors that has maintained its growth momentum. Pharmaceutical exports during the period April–February FY26 stood at USD 28.29 billion, reflecting a growth of 5.6 per cent compared to the same period in FY25 led by formulations, biologicals, vaccines and Ayush products," he said.
The official further said the exports reached USD 30.47 billion in FY 2024–25, reflecting a growth of 9.4 percent year on year despite global pricing pressures and trade volatilities.. PTI GDK SA
Indian pharmaceutical exports maintain growth momentum as formulations, biologicals, vaccines and Ayush products lead performance. Indian pharmaceutical exports maintained growth momentum despite global pricing pressures and trade volatilities, with shipments reaching over USD 28 billion up to February in FY26 and registering year-on-year growth of 5.6 per cent over the corresponding period in FY25. Export performance was led by formulations, biologicals, vaccines and Ayush products.Press 'Enter' after typing page number.